Lorenzo Depau
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin.
Journal: Frontiers in cell and developmental biology
Published: October 03, 2024
Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
Journal: Journal of medicinal chemistry
Published: December 07, 2020
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Journal: Cell
Published: November 24, 2020
Endocytosis and Trafficking of Heparan Sulfate Proteoglycans in Triple-Negative Breast Cancer Cells Unraveled with a Polycationic Peptide.
Journal: International journal of molecular sciences
Published: September 07, 2020
A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment.
Journal: Molecules (Basel, Switzerland)
Published: January 24, 2020
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity.
Journal: Frontiers in oncology
Published: April 18, 2019
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells.
Journal: PloS one
Published: January 02, 2018
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging.
Journal: Journal of nanobiotechnology
Published: November 21, 2017
Hyaluronan-based graft copolymers bearing aggregation-induced emission fluorogens.
Journal: RSC advances
Published: November 17, 2017
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.
Journal: Oncotarget
Published: April 21, 2017
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug.
Journal: Scientific reports
Published: August 19, 2015
Last Updated: 09/26/2026